UPDATE: Cowen Downgrades bluebird bio (BLUE) to Market Perform
Tweet Send to a Friend
(Updated - April 6, 2022 3:19 AM EDT)
Cowen analyst Yaron Werber downgraded bluebird bio (NASDAQ: BLUE) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Yaron Werber downgraded bluebird bio (NASDAQ: BLUE) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
